Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Equity Income: 2010-2014

Historic Equity Income for Arrowhead Pharmaceuticals (ARWR) over the last 5 years, with Sep 2014 value amounting to -$78,874.

  • Arrowhead Pharmaceuticals' Equity Income rose 149.33% to $78,702 in Q2 2014 from the same period last year, while for Jun 2014 it was -$1.7 million, marking a year-over-year decrease of 24.54%. This contributed to the annual value of -$78,874 for FY2014, which is 87.70% up from last year.
  • Arrowhead Pharmaceuticals' Equity Income amounted to -$78,874 in FY2014, which was up 87.70% from -$641,141 recorded in FY2013.
  • Arrowhead Pharmaceuticals' Equity Income's 5-year high stood at -$78,874 during FY2014, with a 5-year trough of -$641,141 in FY2013.
  • For the 3-year period, Arrowhead Pharmaceuticals' Equity Income averaged around -$320,056, with its median value being -$240,154 (2012).
  • In the last 5 years, Arrowhead Pharmaceuticals' Equity Income slumped by 166.97% in 2013 and then surged by 87.70% in 2014.
  • Yearly analysis of 5 years shows Arrowhead Pharmaceuticals' Equity Income stood at -$219,540 in 2010, then climbed by 25.67% to -$163,180 in 2011, then plummeted by 47.17% to -$240,154 in 2012, then slumped by 166.97% to -$641,141 in 2013, then skyrocketed by 87.70% to -$78,874 in 2014.